Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Monte Rosa Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 6.8M | $129M | $19.00 | Jun 28, 2021 | By Versant Venture Capital VI, L.P. |
Monte Rosa Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 2.1M | $39.9M | $19.00 | Jun 28, 2021 | By Versant Vantage I, L.P. |
Monte Rosa Therapeutics, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 47.1K | Jun 23, 2021 | Direct | ||
Black Diamond Therapeutics, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 15K | Jun 18, 2021 | Direct | ||
CRISPR Therapeutics AG | Director | Stock Option (Right to Buy) | 12K | Jun 9, 2022 | Direct | ||
Monte Rosa Therapeutics, Inc. | Director, 10%+ Owner | Series A convertible preferred stock | 0 | Jun 28, 2021 | By Versant Capital VI, L.P. | ||
Monte Rosa Therapeutics, Inc. | Director, 10%+ Owner | Series B convertible preferred stock | 0 | $2.00 | Jun 28, 2021 | By Versant Capital VI, L.P. | |
Monte Rosa Therapeutics, Inc. | Director, 10%+ Owner | Series B convertible preferred stock | 0 | $2.00 | Jun 28, 2021 | By Versant Vantage I, L.P. | |
Monte Rosa Therapeutics, Inc. | Director, 10%+ Owner | Series C convertible preferred stock | 0 | Jun 28, 2021 | By Versant Vantage I, L.P. |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CRSP | CRISPR Therapeutics AG | Jun 9, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
CRSP | CRISPR Therapeutics AG | Jul 19, 2021 | 4 | -$1.26M | 4 | Jul 21, 2021 | Director |
CRSP | CRISPR Therapeutics AG | Jun 28, 2021 | 25 | -$7.11M | 4 | Jun 30, 2021 | Director |
CRSP | CRISPR Therapeutics AG | Jun 28, 2021 | 14 | -$4.63M | 4 | Jun 30, 2021 | Director |
GLUE | Monte Rosa Therapeutics, Inc. | Jun 28, 2021 | 7 | $3M | 4 | Jun 30, 2021 | Director, 10%+ Owner |
GLUE | Monte Rosa Therapeutics, Inc. | Jun 23, 2021 | 0 | $0 | 3 | Jun 23, 2021 | Director, 10%+ Owner |
BDTX | Black Diamond Therapeutics, Inc. | Jun 18, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director, 10%+ Owner |
CRSP | CRISPR Therapeutics AG | Jun 11, 2021 | 5 | -$1.27M | 4 | Jun 15, 2021 | Director |
CRSP | CRISPR Therapeutics AG | Jun 10, 2021 | 1 | $0 | 4 | Jun 14, 2021 | Director |
GLUE | Monte Rosa Therapeutics, Inc. | Feb 24, 2021 | 4 | $15.1M | 4 | Jun 25, 2021 | Director, 10%+ Owner |